| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |